Skip to main content
Friday, October 30, 2026Oct 30

This story is free to read.

‘Magic mushroom’ psychedelic may ease anxiety, depression

In this Monday, Nov. 28, 2016 photo, Dinah Bazer poses at her home in New York. Bazer found relief from cancer anxiety by being treating with a dose of psilocybin administered by a New York University study. Two studies, published Thursday, Dec. 1, 2016, say a single dose of the psychedelic ingredient in “magic mushrooms” can quickly and effectively treat anxiety and depression in cancer patients, an effect that may last for months.  (AP Photo/Bebeto Matthews)
In this Monday, Nov. 28, 2016 photo, Dinah Bazer poses at her home in New York. Bazer found relief from cancer anxiety by being treating with a dose of psilocybin administered by a New York University study. Two studies, published Thursday, Dec. 1, 2016, say a single dose of the psychedelic ingredient in “magic mushrooms” can quickly and effectively treat anxiety and depression in cancer patients, an effect that may last for months. (AP Photo/Bebeto Matthews) In this Monday, Nov. 28, 2016 photo, Dinah Bazer poses at her home in New York. Bazer found relief from cancer anxiety by being treating with a dose of psilocybin administered by a New York University study. Two studies, published Thursday, Dec. 1, 2016, say a single dose of the psychedelic ingredient in “magic mushrooms” can quickly and effectively treat anxiety and depression in cancer patients, an effect that may last for months. (AP Photo/Bebeto Matthews)

NEW YORK (AP) – The psychedelic drug in “magic mushrooms” can quickly and effectively help treat anxiety and depression in cancer patients, an effect that may last for months, two small studies show.

It worked for Dinah Bazer, who endured a terrifying hallucination that rid her of the fear that her ovarian cancer would return. And for Estalyn Walcoff, who says the drug experience led her to begin a comforting spiritual journey.

The work released Thursday is preliminary and experts say more definitive research must be done on the effects of the substance, called psilocybin (sih-loh-SY’-bihn).

But the record so far shows “very impressive results,” said Dr. Craig Blinderman, who directs the adult palliative care service at the Columbia University Medical Center/New York-Presbyterian Hospital. He didn’t participate in the work.

Psilocybin, also called shrooms, purple passion and little smoke, comes from certain kinds of mushrooms. It is illegal in the U.S., and if the federal government approves the treatment, it would be administered in clinics by specially trained staff, experts say.